Targeting two brain tumor-associated proteins-;rather than one-;with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical trial led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center.
Pakistan recalls altered dose of Avastin; FDA rejects Botanix gel
Plus, MC2’s new licensing deal with Regranion and AM-Pharma announces a new CEO and workforce cuts. Pakistan recalls altered Avastin Pakistan is pulling a dose
September 27, 2023